Last week I blogged about the issues surrounding diabetes drug Avantia as featured in BBC’s Panorama documentary.
There has been growing concern since 2007 when the Senate Finance Committee launched an investigation into the safety of the drug and the conduct of manufacturer GlaxoSmithKline. This was prompted by research published in the New England Journal of Medicine which had linked use of the drug to a 43% increase in heart attack risk.
Senate Investigation Showed Drug Manufacturer Aware Of Risk
The results of the Senate investigation were made public in October 2010 and were shocking in so much as they indicated that GlaxoSmithKline had been aware of the cardiacrelat